| Financial Year |
March 31 2023 |
| Monetary Funds |
660,114,649.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
33,477,660.00 |
| Accounts Receivable |
604,933,774.92 |
| Advances to Suppliers |
57,861,247.89 |
| Other Receivables |
37,159,539.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
245,404,791.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,139,701.56 |
| Total Current Assets |
1,857,645,015.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
549,791.08 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
210,279,986.12 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,437,240.08 |
| R&D expenses |
-- |
| Goodwill |
160,752,501.13 |
| Long-Term Deferred and Prepaid Expenses |
1,366,003.50 |
| Deferred Income Tax Assets |
19,089,658.05 |
| Other Non-Current Assets |
59,054,645.22 |
| Sub-Total of Non-Current Assets |
575,373,173.27 |
| Total Assets |
2,433,018,188.28 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
65,187,928.50 |
| Accounts Payable |
420,829,292.75 |
| Accounts Received In Advance |
2,377,811.38 |
| Employee Compensation Payable |
31,424,645.81 |
| Taxes Payable |
11,722,960.18 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,968,062.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
34,198,614.07 |
| Other Current Liabilities |
6,171,164.26 |
| Sub-Total of Current Liabilities |
683,173,920.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
64,465,982.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,535,319.00 |
| Other Non-Current Liabilities |
3,382,501.27 |
| Sub-Total of Non-Current Liabilities |
78,312,707.40 |
| Total Liabilities |
761,486,628.31 |
| Paid-In Capital(Or Share Stock) |
664,210,505.00 |
| Capital Surplus |
1,228,919,429.85 |
| Surplus Reserve |
2,973,041.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-482,679,040.93 |
| Minority Stockholder's Interest |
259,941,844.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,411,589,715.88 |
| Owner's Equity（Stockholder's Equity） |
1,671,531,559.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,433,018,188.28 |
